All the pathological changes above were remarkably prevented by FGF21 supplement (Fig. S14A−F), indicating that FGF21 prevented T2DM-induced cardiomyopathy via the inhibition of lipotoxicity rather than glucose toxicity. Here, FGF21 is linked to cardiomyopathy.